InvestSMART

Orthocell Limited (ASX: OCC) - Share Price

Current share price for OCC : $0.760 0.04 (5.56%)+

Orthocell Limited (OCC), an ASX-listed company, operates as a regenerative medicine company engaged in developing products for the repair of bone and soft tissue injuries. The company has appointed a network of specialist distributors in the United States and recorded initial sales. The company's nerve repair product holds approval in Australia, New Zealand and Singapore and is distributed through Device Technologies Group in those markets.

OCC General Information +

ASX Code OCC
Website N/A
Industry/Sector Biotechnology
Market Cap ($M) 206
OCC Share Price $0.760
Day High $0.760
Day Low $0.708
Last Close $0.720
OCC Share Price Movement $0.04 ( 5.56% )
Prices as at 16:40, 26 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Orthocell Limited (OCC) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Orthocell Limited (OCC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Orthocell Limited (OCC) price-sensitive announcements

OCC - First Sales of Remplir Achieved in US$75m Canadian Market
Orthocell Limited has achieved its first commercial sales of the nerve repair device Rempl
Orthocell Limited (OCC)
30 Apr 2026 | 9:14 AM
OCC - Compelling 90% Success Rate for Remplir in Real World Study
Orthocell Limited announced that their product, Remplir™, achieved a 90% success rate in a
Orthocell Limited (OCC)
28 Apr 2026 | 9:10 AM
OCC - Q3 FY26 Investor Presentation
Orthocell Limited's Q3 FY26 Investor Presentation highlights significant growth and strate
Orthocell Limited (OCC)
20 Apr 2026 | 9:05 AM
OCC - Quarterly Activity Report & Appendix 4C
Orthocell Limited reported robust financial performance in its Quarterly Activity Report f
Orthocell Limited (OCC)
20 Apr 2026 | 9:04 AM

Orthocell Limited (OCC) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Cleansing Notice 14 May 2026 4:15PM $0.830 $0.760 fallen by 8.43%
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Application for quotation of securities - OCC 14 May 2026 4:11PM $0.830 $0.760 fallen by 8.43%
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Cleansing Notice 5 May 2026 4:22PM $0.855 $0.760 fallen by 11.11%
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Application for quotation of securities - OCC 5 May 2026 4:19PM $0.855 $0.760 fallen by 11.11%
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Appendix 3Y - Michael McNulty 4 May 2026 9:39AM $0.900 $0.760 fallen by 15.56%
Orthocell Limited (OCC)
ORDINARY FULLY PAID
Health Care $207 Appendix 3Y - John Van Der Wielen 4 May 2026 9:36AM $0.900 $0.760 fallen by 15.56%

OCC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2027F C2 -$2.00 -50.00% 0.00 0.00 0.00% 0.0%
2026F C2 -$4.00 4.20% 0.00 0.00 0.00% 0.0%
2025A -$8.57 -$3.80 8.20% 0.00 0.00 0.00% 0.0%

OCC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2025 A 2026 F 2027 F 2025 A 2026 F 2027 F 2025 A 2026 F 2027 F
CSL Limited (CSL) $56,344M 0.1108 -0.1296 0.0166 12.6157 14.4937 14.2573 3.79% 3.06% 3.19%
Clinuvel Pharmaceuticals Limited (CUV) $507M 0.0287 -0.0028 0.1257 13.9972 14.0363 12.4690 0.50% 0.70% 1.53%
Mesoblast Limited (MSB) $2,693M 0.0301 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Orthocell Limited (OCC) $196M 0.0817 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Telix Pharmaceuticals Limited (TLX) $5,321M -1.3893 0.0000 -0.1304 0.0000 291.9926 335.7602 0.00% 0.00% 0.00%

OCC Directors

Name Position Start Date
Mr Paul Frederick Anderson Chief Executive Officer, Managing Director 21 Mar 2006
Dr Ravi Thadhani Lead Independent Director, Non-Executive Director 8 Mar 2023
Mr John Van Der Wielen Non-Executive Chairman, Non-Executive Director 1 Jun 2023
Professor Fiona Melanie Wood Non-Executive Director 1 Nov 2023
Mr Michael McNulty Non-Executive Director 1 Sep 2025

Orthocell Limited (OCC) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
1 May 2026 WIELEN, John Buy Indirect Shares 25,000 $0.932 $23,310.000
30 Apr 2026 MCNULTY, Michael Buy Indirect Shares 23,615 $0.891 $21,050.800
25 Feb 2026 WIELEN, John Buy Indirect Shares 32,500 $0.964 $31,337.000

See all changes in directors' interest & trades for Orthocell Limited (OCC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

OCC Management

Name Position
Peter Webse Company Secretary

OCC Calendar of Events

Date Event
23 February 2027 Report (Interim)
02 October 2026 Report (Annual)
28 August 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.